The Relevance of New Drug Combinations for Modern Tuberculosis Treatment - A Patent Perspective

E-ISSN： 2212-4071|8|2|130-138

ISSN： 1574-891X

Source： Recent Patents on Anti-Infective Drug Discovery, Vol.8, Iss.2, 2013-08, pp. : 130-138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New guidelines for the treatment of tuberculosis

By Habeck M.

The Lancet Infectious Diseases, Vol. 3, Iss. 5, 2003-05 ,pp. : 265-265

Elsevier

Access to resources Recommend Favorite

Diagnosis and Treatment of Drug-Resistant Tuberculosis: State of the Art

Current Respiratory Medicine Reviews, Vol. 13, Iss. 2, 2017-12 ,pp. : 73-81

Bentham Science Publishers

Access to resources Recommend Favorite

Preclinical Study of New TB Drugs and Drug Combinations in Mouse Models

Recent Patents on Anti-Infective Drug Discovery, Vol. 3, Iss. 2, 2008-06 ,pp. : 102-116

Bentham Science Publishers

Access to resources Recommend Favorite

Outcomes of clofazimine for the treatment of drug-resistant tuberculosis: a systematic review and meta-analysis

By Dey Teesta Brigden Grania Cox Helen Shubber Zara Cooke Graham Ford Nathan

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 2, 2013-02 ,pp. : 284-293

Oxford University Press

Access to resources Recommend Favorite

Progress and Prospects of Stem Cells in Treatment of Drug Resistant Tuberculosis

Current Respiratory Medicine Reviews, Vol. 10, Iss. 4, 2014-12 ,pp. : 230-237

Bentham Science Publishers

Access to resources Recommend Favorite